Default company panoramic image
A3e6d283 48ec 46e7 bd41 1269647d2652

Evestra, Inc.

Evestra's mission is to develop and commercialize novel steroid products in female healthcare to treat unmet medical need indications.

  • Stage Concept Only
  • Industry Biotechnology
  • Location San Antonio, TX, USA
  • Currency USD
  • Founded October 2001
  • Employees 9
  • Website

Company Summary

Evestra is a biopharm R&D company conducting research and product development in several needs in the areas of female health (endometriosis, fibroids, fertility control, HRT and hormonal-dependent breast cancer). Novel drug candidates are designed via structure-activity relationship constituting the next generation of steroidal drugs. A 37-yr collaboration with the NIH provides outside validation of Evestra's expertise plus non-dilutive revenue.


  • Default avatar
    Ze'ev Shaked
    President & CEO

    Extensive managerial and pharmaceutical product development experience in commercializing biologics and conventional drugs includes former President/CEO Spherics; President of ILEX Products and CEO of ILEX Oncology plus a number of senior R&D corporate management postions at ImmuLogic Pharaceutical Corp., Berliex Biosciences, Inc. Triton Biosciences, Inc., CODON Corp. and Chron Corp. PhD in organic and applied biochemistry from MIT.

  • Default avatar
    Klaus Nickisch

    More than 28 years of project management and department leadership experience with Schering AG specializing in the areas of chemical development of medicinal applications in oncology and female health. Head of project and portfolio management of the Specialized Therapeutics unit at Berlex. Head of Global Project Management, Berlex. PhD in organic chemistry from the Technical University of Berlin.

  • Default avatar
    Maika Friedrich
    Global Project Manager


  • Default avatar
    Drew Fuller - Hornberger Sheehan Fuller & Beiter
    Default avatar
    Carolyne Packenius

Previous Investors

  • Default avatar
    Local private investors